Why Clinical Trials Fail?

Slow

Clinical trials take

2–7 years on average

Expensive

Phase II & III failures

cost $10M–$100M+ per trial

Failures happen too late

Over 70% of drugs fail

due to lack of efficacy or safety

Not enough participants

Decisions are made with

limited patient-level predictability

Our Solution:

Virtual Clinical Trials Using

Human Digital Twins

Xtwin creates virtual populations of AI-generated human digital twins to simulate treatment outcomes before running real clinical trials.

Step 1. Digital Twin Creation

We generate virtual patients using biological, demographic, and clinical data.

Step 2. AI-Driven Simulation

Treatments are simulated across thousands of digital participants in minutes.

Step 3. Predictive Insights

Sponsors receive outcome forecasts, risk signals, and confidence scores.

What This Means for Sponsors?

✅Faster decisions:

simulate trials in minutes instead of months

✅Lower risk:

identify failure signals before human trials

✅Lower cost:

reduce unnecessary trial phases

✅Better design:

optimize inclusion criteria and endpoints early

Current Status & Validation

Let’s Make Healthcare Options Better Together

Partners, investors, and clinicians, are invited to connect with us. Whether you want to provide feedback, explore collaboration, or support our mission, we welcome your outreach and personally review every message we receive.

Let's Connect

B2B

Xtwin is offered as a SaaS platform to pharma and biotech companies.

💳 Subscription licensing

💳 Per-trial pricing

💳 Enterprise access for R&D teams

world-class team

We are passionate about pioneering futuristic technologies in healthcare.

Contact info

Sara Amiri

Technical co-founder

Biomedical Informatics Engineer

Human Digital Twin Developer

Page updated

Google Sites

Report abuse